PER 2.41% 8.1¢ percheron therapeutics limited

FDA review re Sarepta 21/6/24 expanded gene therapy, page-2

  1. 35,698 Posts.
    lightbulb Created with Sketch. 552
    lol FDA is not going to do what some broker says - FDA will do as FDA will do ....


    I do think 5051 will probably phase out Exondy's though given the drastic increase - that meetings Q3
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
-0.002(2.41%)
Mkt cap ! $73.02M
Open High Low Value Volume
8.1¢ 8.2¢ 8.0¢ $39.27K 485.4K

Buyers (Bids)

No. Vol. Price($)
1 365000 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 57142 1
View Market Depth
Last trade - 14.51pm 11/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.